Table Of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of North America Market by Component	41
3.1 Market Overview by Component	41
3.2 Instruments	43
3.3 Consumables	45
3.4 Software	47
3.5 Services	49
4 Segmentation of North America Market by Technology	50
4.1 Market Overview by Technology	50
4.2 Polymerase Chain Reaction (PCR)	52
4.3 Next-Generation Sequencing	54
4.4 Microarray	56
4.5 In-Situ Hybridization (ISH)	58
4.6 Gene Regulation Technologies	60
4.7 Other Technologies	61
5 Segmentation of North America Market by Application	62
5.1 Market Overview by Application	62
5.2 Drug Discovery and Development	64
5.3 Diagnostics	65
5.4 Single Cell Analysis	66
5.5 Gene Expression	67
5.6 Cell Biology	68
5.7 Other Applications	69
6 Segmentation of North America Market by End User	70
6.1 Market Overview by End User	70
6.2 Academic and Research Institutions	72
6.3 Biotechnology and Biopharmaceutical Companies	73
6.4 Contract Research Organizations (CROs)	74
6.5 Other End Users	75
7 North America Market 2021-2031 by Country	76
7.1 Overview of North America Market	76
7.2 U.S.	79
7.3 Canada	82
7.4 Mexico	84
8 Competitive Landscape	86
8.1 Overview of Key Vendors	86
8.2 New Product Launch, Partnership, Investment, and M&A	91
8.3 Company Profiles	92
10x Genomics	92
Agilent Technologies, Inc.	94
ANGLE plc	95
Becton, Dickinson and Company (BD)	96
Bio-Rad Laboratories, Inc.	97
BioSypder, Inc.	98
Bio-Techne	99
Cytiva	100
F. Hoffmann-La Roche Ltd.	101
Fluidigm Corporation	102
GE Healthcare	103
Illumina, Inc.	104
Menarini Silicon Biosystems	105
Merck & Co., Inc.	106
NanoString	107
Pacific Biosciences of California, Inc.	108
PerkinElmer Inc.	109
Promega Corporation	110
Qiagen N. V.	111
Takara Bio Inc.	112
Thermo Fisher Scientific Inc.	113
RELATED REPORTS	114

List Of Tables:


Table 1.  Snapshot of North America Transcriptomics Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. Transcriptome Databases	28
Table 4. World Personalized Medicine Market, 2021-2031, $ bn	29
Table 5.  Main Product Trends and Market Opportunities in North America Transcriptomics Market	33
Table 6. North America Transcriptomics Market by Component, 2021-2031, $ mn	41
Table 7. Main Instrument Products from Key Vendors	44
Table 8. Main Consumable Products from Key Vendors	46
Table 9. Main Software Products from Key Vendors	48
Table 10. North America Transcriptomics Market by Technology, 2021-2031, $ mn	50
Table 11. Main PCR-based Transcriptomics and Key Vendors	53
Table 12. Main NGS-based Transcriptomics and Key Vendors	55
Table 13. Main Microarray-based Transcriptomics and Key Vendors	57
Table 14. Main ISH-based Transcriptomics and Key Vendors	59
Table 15. North America Transcriptomics Market by Application, 2021-2031, $ mn	62
Table 16. North America Transcriptomics Market by End User, 2021-2031, $ mn	70
Table 17. North America Transcriptomics Market by Country, 2021-2031, $ mn	77
Table 18. U.S. Transcriptomics Market by Component, 2021-2031, $ mn	81
Table 19. U.S. Transcriptomics Market by Technology, 2021-2031, $ mn	81
Table 20. U.S. Transcriptomics Market by Application, 2021-2031, $ mn	81
Table 21. Canada Transcriptomics Market by Component, 2021-2031, $ mn	83
Table 22. Canada Transcriptomics Market by Technology, 2021-2031, $ mn	83
Table 23. Canada Transcriptomics Market by Application, 2021-2031, $ mn	83
Table 24. Mexico Transcriptomics Market by Component, 2021-2031, $ mn	85
Table 25. Mexico Transcriptomics Market by Technology, 2021-2031, $ mn	85
Table 26. Mexico Transcriptomics Market by Application, 2021-2031, $ mn	85
Table 27. Transcriptomic Products Approved by FDA	88
Table 28. Sequencing Technology Platforms for RNA-Sequencing	89
Table 29. RNA-Sequencing De Novo Assembly Software	89
Table 30. 10x Genomics: Company Snapshot	92
Table 31. 10x Genomics: Business Segmentation	93
Table 32. 10x Genomics: Product Portfolio	93

List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. North America Transcriptomics Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of North America Transcriptomics Market	25
Figure 7. Primary Restraints and Impact Factors of North America Transcriptomics Market	30
Figure 8. Investment Opportunity Analysis	34
Figure 9. Porter’s Fiver Forces Analysis of North America Transcriptomics Market	37
Figure 10. Breakdown of North America Transcriptomics Market by Component, 2021-2031, % of Revenue	42
Figure 11. North America Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%)	42
Figure 12. North America Transcriptomics Market by Component: Instruments, 2021-2031, $ mn	43
Figure 13. North America Transcriptomics Market by Component: Consumables, 2021-2031, $ mn	45
Figure 14. North America Transcriptomics Market by Component: Software, 2021-2031, $ mn	47
Figure 15. North America Transcriptomics Market by Component: Services, 2021-2031, $ mn	49
Figure 16. Breakdown of North America Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue	51
Figure 17. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)	51
Figure 18. North America Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn	52
Figure 19. North America Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn	54
Figure 20. North America Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn	56
Figure 21. North America Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn	58
Figure 22. North America Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn	60
Figure 23. North America Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn	61
Figure 24. Breakdown of North America Transcriptomics Market by Application, 2021-2031, % of Sales Revenue	63
Figure 25. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	63
Figure 26. North America Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn	64
Figure 27. North America Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn	65
Figure 28. North America Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn	66
Figure 29. North America Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn	67
Figure 30. North America Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn	68
Figure 31. North America Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn	69
Figure 32. Breakdown of North America Transcriptomics Market by End User, 2021-2031, % of Revenue	71
Figure 33. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	71
Figure 34. North America Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn	72
Figure 35. North America Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn	73
Figure 36. North America Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn	74
Figure 37. North America Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn	75
Figure 38. Breakdown of North America Transcriptomics Market by Country, 2021 and 2031, % of Revenue	77
Figure 39. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	78
Figure 40. U.S. Transcriptomics Market, 2021-2031, $ mn	80
Figure 41. Canada Transcriptomics Market, 2021-2031, $ mn	82
Figure 42.  Transcriptomics Market in Mexico, 2021-2031, $ mn	84
Figure 43. Growth Stage of North America Transcriptomics Industry over the Forecast Period	86

Selected Key Players: 
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)